RVMD - Revolution Medicines, Inc.
101.19
0.700 0.692%
Share volume: 1,561,782
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$100.49
0.70
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-06-2024 | 02-26-2025 | 05-07-2025 | 11-05-2025 | 02-25-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 140.859 M | 156.643 M | 175.712 M | 216.310 M | 240.760 M | 315.269 M | 361.626 M | |
| Selling general and admin | 22.838 M | 21.711 M | 23.960 M | 28.790 M | 35.011 M | 52.763 M | 66.683 M | |
| Research and development | 118.021 M | 134.932 M | 151.752 M | 187.520 M | 205.749 M | 262.506 M | 294.943 M | |
| Total expenses | 140.859 M | 156.643 M | 175.712 M | 216.310 M | 240.760 M | 315.269 M | 361.626 M | |
| 11.21% | 12.17% | 23.10% | 11.30% | 30.95% | 14.70% | |||
| Operating income | -140.859 M | -156.643 M | -175.712 M | -216.310 M | -240.760 M | -315.269 M | -361.626 M | |
| Ebit | -140.859 M | -154.720 M | -175.430 M | -222.139 M | -238.331 M | -315.861 M | -374.280 M | |
| Pretax income | -116.003 M | -133.233 M | -156.288 M | -195.322 M | -213.416 M | -305.206 M | -364.892 M | |
| 14.85% | 17.30% | 24.98% | 9.26% | 43.01% | 19.56% | |||
| Income tax | 0.000 | 0.000 | 0.000 | -753.000 K | 0.000 | 0.000 | 0.000 | |
| Net income basic | -116.003 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | ||||||||
| Net income | -116.003 M | -133.233 M | -156.288 M | -194.569 M | -213.416 M | -305.206 M | -364.892 M | |
| -14.85% | -17.30% | -24.49% | -9.69% | -43.01% | -19.56% |